Amryt Pharma (AMYT)
NASDAQ:AMYT

Amryt Pharma Financial Statements

78 Followers

Amryt Pharma Financial Overview

Amryt Pharma's market cap is currently ―. The company's EPS TTM is $-0.39; its P/E ratio is -18.71; Amryt Pharma is scheduled to report earnings on March 8, 2023, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement
Total Revenue$ 61.13M$ 68.54M$ 59.13M$ 54.83M$ 56.52M
Gross Profit$ 27.42M$ 35.17M$ 28.35M$ 25.64M$ 29.25M
EBIT$ -11.74M$ -189.00K$ -13.89M$ 52.01M$ -26.31M
EBITDA$ 5.23M$ 14.68M$ 935.00K$ 52.01M$ -26.31M
Net Income Common Stockholders$ -20.80M$ -7.05M$ -14.49M$ 41.55M$ -17.21M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 83.25M$ 90.58M$ 102.17M$ 112.77M$ 123.13M
Total Assets$ 736.88M$ 764.74M$ 786.87M$ 816.06M$ 855.46M
Total Debt$ 212.79M$ 217.23M$ 206.46M$ 199.18M$ 202.13M
Net Debt$ 129.54M$ 126.65M$ 104.29M$ 86.41M$ 79.00M
Total Liabilities$ 412.60M$ 422.71M$ 440.88M$ 459.40M$ 549.44M
Stockholders Equity$ 324.28M$ 342.03M$ 345.98M$ 356.66M$ 306.02M
Cash Flow
Free Cash Flow$ 14.00M$ -6.20M$ -7.96M$ 106.81M$ -124.45M
Operating Cash Flow$ 14.34M$ -5.96M$ -7.54M$ 107.43M$ -124.33M
Investing Cash Flow$ -16.43M$ -222.00K$ -421.00K$ -621.00K$ 107.82M
Financing Cash Flow$ -5.06M$ -3.48M$ -2.67M$ -116.92M$ -1.75M
Currency in USD

Amryt Pharma Earnings and Revenue History


Amryt Pharma Debt to Assets


Amryt Pharma Cash Flow


Amryt Pharma Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis